Benzinga · Aug 24, 2026
Maxim Group Downgrades NexGel to Hold
Maxim Group analyst Naz Rahman downgrades NexGel (NASDAQ:NXGL) from Buy to Hold.
NX
NASDAQ · NXGL
NEXGEL, Inc.
Healthcare · Medical - Instruments & Supplies
$0.28
Down-$0.01 (-3.59%)
Updated Sep 16, 2026, 3:47 PM
SID Score
2.4/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 19.39M
- P/E ratio
- -4.77
- Dividend yield
- 0.00%
- 52-week range
- $0.27 – $2.89
- Volume
- 69.01K
- Avg. volume
- 65.95K
Price performance
NXGL price history
1M range · 20 trading sessions · Daily adjusted prices
NXGL closed at $0.28 after 20 trading sessions, down 26.89% for the selected period.
- Last close
- $0.28
- Period change
- -26.89%
- Period low
- $0.28
- Period high
- $0.40
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 15, 2026 | $0.277 | $0.2909 | $0.277 | $0.2811 | 69.01K |
| Sep 14, 2026 | $0.286 | $0.29 | $0.2749 | $0.2807 | 66.42K |
| Sep 11, 2026 | $0.286 | $0.2952 | $0.2809 | $0.2911 | 90.05K |
| Sep 10, 2026 | $0.2856 | $0.297 | $0.2702 | $0.2901 | 1.51M |
| Sep 9, 2026 | $0.2955 | $0.30 | $0.2866 | $0.2986 | 108.93K |
| Sep 8, 2026 | $0.3202 | $0.33 | $0.2859 | $0.2973 | 160.63K |
| Sep 4, 2026 | $0.339 | $0.339 | $0.308 | $0.3165 | 93.09K |
| Sep 3, 2026 | $0.3461 | $0.3539 | $0.336 | $0.3394 | 97.78K |
| Sep 2, 2026 | $0.3576 | $0.3771 | $0.3394 | $0.3474 | 152.73K |
| Sep 1, 2026 | $0.3487 | $0.3699 | $0.3317 | $0.358 | 171.99K |
| Aug 31, 2026 | $0.336 | $0.3632 | $0.3341 | $0.3588 | 188.47K |
| Aug 28, 2026 | $0.341 | $0.3591 | $0.3338 | $0.352 | 196.12K |
| Aug 27, 2026 | $0.3453 | $0.37 | $0.3284 | $0.3499 | 331.26K |
| Aug 26, 2026 | $0.36 | $0.37 | $0.3401 | $0.356 | 237.52K |
| Aug 25, 2026 | $0.358 | $0.3911 | $0.3539 | $0.356 | 539.31K |
| Aug 24, 2026 | $0.3075 | $0.38 | $0.3001 | $0.38 | 25.01M |
| Aug 21, 2026 | $0.37 | $0.37 | $0.3292 | $0.33 | 350.66K |
| Aug 20, 2026 | $0.4038 | $0.4038 | $0.3782 | $0.3873 | 552.57K |
| Aug 19, 2026 | $0.381 | $0.417 | $0.37 | $0.4039 | 87.75K |
| Aug 18, 2026 | $0.355 | $0.4092 | $0.355 | $0.3845 | 179.82K |
Latest NXGL news
The latest Smart Investors Daily articles mentioning NXGL.
Stock researchCompany · Overview
NXGL research
Overview
Company profile and research snapshot.
Company profile
NexGel Inc manufactures high water content, electron beam cross-linked, aqueous polymer hydrogels, or gels, used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company specializes in custom gels by capitalizing on proprietary manufacturing technologies. The gels and consumer products are manufactured using proprietary and non-proprietary mixing, coating and cross-linking technologies.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- —
- Implied upside
- —
- Analysts
- —
| Date | Firm | Rating | Target |
|---|---|---|---|
| Aug 24, 2026 | Maxim Group | Hold | — |
| Mar 12, 2026 | Maxim Group | Buy | — |
| Feb 25, 2022 | Maxim Group | Buy | — |
News briefing
No generated briefing is available yet.
Benzinga · Aug 21, 2026
Deal Dispatch: MunichRe Buys At-Bay, Mavis Tire Closes Pep Boys Purchase, Werewolf Merges With Ambros
Major M&A deals include: T Rowe Price buys F/M Investments, ScanSource acquires CleanWater1, Barrington & Burdette filed for bankruptcy.
Benzinga · Aug 21, 2026
12 Health Care Stocks Moving In Friday's Intraday Session
Gainers Werewolf Therapeutics (NASDAQ:HOWL) shares increased by 108.1% to $0.9 during Friday's regular session. The market value of their outstanding shares is at $20.9 million. Jupiter Neurosciences (NASDAQ:JUNS)
Benzinga · Aug 20, 2026
NEXGEL Appoints Brian Kieser As Interim CEO; Co. Forms Special Committee For Strategic Review And Value Creation
NEXGEL, Inc. ("NEXGEL" or the "Company") (NASDAQ: "NXGL") today announced a series of leadership, governance and strategic initiatives designed to strengthen operational execution, improve
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
